Flyer feb 2013.pptx

!
Interna'onal*congress*on*
*Cancer*cell*death**
*and*resistance
May 6 and 7, 2013
Golf of Seilh
Near to Toulouse (Midi-Pyrénées, 31, France)
!"#$%%&'())*(+,!-.'/(0'(.'102-1345

Introduction
Content5$55
! !"#$%&'(#)%"*
! +,",$-.*/$,0,"#-#)%"*
! 1$%2$-3*
! 4%33)##,,0*
! 5/%"0%$0*
*
6(./.,+0'(5 ,15 +078'+0'(35 3(4/9(0.5 +0*5 ,15 ,!(5 /99:0(5 .;.,(95 '10,3/<:,(.5 ,15
'+0'(35 #3143(../105 +0*5 ,!(3+#(:7'5 2+/):3(-5 =!(5 91)(':)+35 9('!+0/.9.>5 ?!/'!5
'10,31)5 ,!(5 3(./.,+0'(5 125 ,:9135 '()).5 ,1?+3*.5 ,!(5 /99:0(5 .;.,(95 +0*5
+07'+0'(35 ,!(3+#/(.5 +3(5 01,5 ;(,5 2:));5 ():'/*+,(*-5 @5 <("(35 &01?)(*4(5 125 ,!(5
./40+)/045 #+,!?+;.5 /0A1)A(*5 /05 <1,!5 #!(019(0+5 .!1:)*5 '10,3/<:,(5 ,15 ,!(5
*(A()1#9(0,512501A()5+078'+0'(35,!(3+#(:7'5.,3+,(4/(.-5
5
=?15 3('(0,5 .'/(07B'5 9((704.5 105 '())5 *(+,!5 /05 10'1)14;5 !+A(5 <((05 3('(0,);5
134+0/C(*5/05D3+0'(5$5
5
=!(5B3.,59((7045?+.5+5?13&.!1#5/05E/F105GH:34:0*;>5D3+0'(I5134+0/C(*5<;5E3-5
J-5K/'!(+:5GLMNO6K5PK65QRRI5/05S:);5TUUV-5=!/.59((7045?+.5(07,)(*5W5E(+,!8
E19+/08'10,+/0/045 3('(#,13.5 +0*5 .'+X1)*5 +*+#,13.5 $5 2:0*+9(0,+)5 +0*5
,!(3+#(:7'5 ,3+/).5 ,15 '+0'(35 +0*5 /99:0(5 */.(+.(.5 Y5 G!"#$%%/0.(398:QRR-:8
<1:34140(-23%Z13&.!1#5 E/F10%+'':(/)[?13&.!1#-!,9)I-5 =!/.5 ?13&.!1#5
2+'/)/,+,(*5,!(5 9((7045125+<1:,5 \U5D3(0'!5+0*5 /0,(30+710+)5.'/(07.,.5+0*5,!(5
(.,+<)/.!9(0,5125'1))+<13+7A(5#31F(',.-55
5
=!+0&.5 ,15 ,!(5 134+0/C+7105 '199/"((5 23195 6(00(.5 GH3/"+0;>5 D3+0'(I5 GE3.-5 ]-5
^(4(9<3(>5 =-5 _:/))+:*(:`>5 K-=-5 E/9+0'!(8H1/,3()I5 +0*5 ,!(5 +'7A(5 #+37'/#+7105
125 .'/(07.,.5 23195 */X(3(0,5 D3(0'!5 )+<13+,13/(.>5 +05 /0,(30+710+)5 '1043(..5
(07,)(*5W5a())5E(+,!5/05'+0'(35Y5?+.5134+0/C(*5/05K+;5TUbT5/05N,5K+)15G!"#$%%
???-'())*(+,!/0'+0'(3-'19%?()'19(-#!#I-5 =!/.5 c8*+;5 '1043(..5 ?+.5 A(3;5
.:''(..2:)5?/,!5b\U5#+37'/#+0,.>5/0'):*/045#3(.74/1:.50+710+)5+0*5/0,(30+710+)5
.#(+&(3.-5
5
=+&/045 /0,15 +''1:0,5 ,!(5 .:''(..5 125 <1,!5 .'/(07B'5 9((704.>5 ,!(5 3(':33(0,5
134+0/C+7105 125 '1043(..5 +##(+3.5 ,15 <(5 (..(07+)5 ,15 .,3:',:3(5 ,!(5 3(.(+3'!5 105
'())5*(+,!5/0510'1)14;5/05D3+0'(-5
5
J05K+;5R8d>5 TUbe>5 ?(5 +3(5 134+0/C/045+05/0,(30+710+)59((7045 105 f'+0'(35 '())5
*(+,!5+0*53(./.,+0'(g5,15<(5!()*5+,5,!(5_1)25125N(/)!>50(+35,15=1:)1:.(85H)+40+'5
@/3#13,5GD3+0'(I-5
5
Web*site*of*the*congress$55!"#$%%&'())*(+,!-.'/(0'(.'102-1345
Z(<5 ./,(5 125 ,!(5 !1,()$5 !"#$%%???-+''13!1,().-'19%23%!1,()8QTcc89(3':3(8
,1:)1:.(841)28*(8.(/)!%/0*(`-.!,9)5

*
" * 6%*3%7).)8,*#9,*:$,"(9*-"&*)"#,$"-#)%"-.*0(),"#);(*(%33'")#),0**
%"*#9,*#%/)(*%<*=(,..*&,-#9*)"*%"(%.%2>?@*
" *6%*$,)"<%$(,*#9,*&>"-3)03*%<*#9,*:$,"(9*$,0,-$(9*)"*#9)0*
(%3/,#)#)A,* ;,.&* 7>* <-().)#-#)"2* #9,* ,0#-7.)093,"#* %<* -* :$,"(9*
",#B%$C*B)#9*&)A,$0,*-"&*(%3/.)3,"#-$>*,D/,$#)0,@*
*
" *6%*<%0#,$*,D(9-"2,0*7,#B,,"*>%'"2*-"&*0,")%$*0(),"#)0#0*-"&*
<-A%$*(%..-7%$-#)A,E*%$)2)"-.*-"&*-37)#)%'0*/$%F,(#0*)"*#9,*%"(%.%2>*
;,.&@*
Main Objectives
Our Ambitions *
" * 6%* /$%/%0,* /$,0#)2)%'0* 0,3)"-$0* 7>* <-3%'0* )"#,$"-#)%"-.*
0/,-C,$0@**
" *6%*/$%/%0,*%$-.*-"&*/%0#,$*(%33'")(-#)%"0*7>*>%'"2*0(),"#)0#0@*
*
69,*(%"2$,00*B)..*7,*%$2-")8,&*)"*Toulouse*B)#9*#9,*/-$#)()/-#)%"*%<*
>%'"2*-"&*0,")%$*0(),"#)0#0*<$%3*-(-&,3)(*-"&*/$)A-#,*.-7%$-#%$),0@*
5
!
!!!!!!!!!
General
Presentation
Main+topics+of+the+congress++:+
+
Apoptosis+signaling+and+resistance+:+
G%A,.* 3%.,('.-$* 3,(9-")030* 3%&'.-#)"2* (-0/-0,* -(#)A-#)%"* -"&*
$,0)0#-"(,*%<*(-"(,$*(,..0@*
*
Alternative+ (non8apoptotic)+ cell+ death+ signaling+ pathways+ and+
resistance+:+
H,(,"#.>* )&,"#);,&* 3%.,('.-$* /-#9B->0* <$%3* &)I,$,"#* %$2-",..,0*
J,"&%/.-03)(* $,#)('.'3E* +%.2)* -//-$-#'0E* .>0%0%3,KLE* 3%&'.-#)"2* (,..*
&,-#9*0)2"-.)"2*)"*(-"(,$*(,..0@*
*
Cancer+cell+death+and+immune+response+:*
M%&'.-#)%"*%<*#9,*-"#)N(-"(,$*)33'",*$,0/%"0,*7>*(,..*&,-#9@*
H,0)0#-"(,*%<*(-"(,$*(,..0*#%*#9,*)33'",*0>0#,3@*

Scientific
program
+May+6,+2013+:+
**
OO@PP*-3N*OQ@PP*-3*R*H,2)0#$-#)%"*-"&*/%0#,$*3%'"#)"2@*
OQ@PP*-3N*Q@PP*/3*R*S'"(9*7'I,#@**
*Q@PP*/3N*Q@OT*/3*R*U,.(%3,*0,00)%"*7>*#9,*%$2-")8,$0**
JV$@*G-#9-.),*W"&$),'NW7-&),E*1$%<@*69),$$>*S,A-&,*-"&*1$%<@*X$'"%*5Y2')E*6%'.%'0,E*
:$-"(,L@*
**
Q@OT*/3N*Z@PP*/3*R*Introducing+lecture+by+Prof.+Henning+Walczak++
J[")A,$0)#>*4%..,2,*S%"&%"E*[")#,&*\)"2&%3L@*
**
Z@PP*/3N*Z@ZP*/3*R*4%I,,*X$,-C*
**
Z@ZP*/3N*T@ZP*/3*R**
Session+1+:+Apoptotic+signaling+and+resistance+
49-)$/,$0%"0R*V$@*4-#9,$)",*1,..-#NV,(,'">"(C*JG-"#,0E*:$-"(,LE**
V$@*1-#$)(C*S,2,37$,*JH,"",0E*:$-"(,LE*V$@*].)A),$*M)(9,-'*JV)F%"E*:$-"(,L*
^*09%$#*%$-.*(%33'")(-#)%"0*JOT*3)"@*/$,0,"#-#)%"*-"&*T*3)"@*&)0('00)%"L*#%*7,*0,.,(#,&*
7>*#9,*0(),"#);(*(%33)##,,@*
**
T@ZP*/3*_*`@ZP*/3*R+Poster+session+1+–+visit+of+stands*
**
a@PP*/3*R*&)"",$*
+*
May+7,+2013+:*
**
a@ZP*-3*_*OP@ZP*-3*R**
Session+2+:+Alternative+(non8apoptotic)+cell+death+signaling+and+resistance.*
49-)$/,$0%"0R*V$@*O3/'5a!(A(,5GH13*(+:`>5D3+0'(I>5E3-5S(+08O!3)+0*56/''/5GM/'(>5D3+0'(I>55
E3-5]!/)/##(5S:/05GM+0,(.>5D3+0'(I**
^*09%$#*%$-.*(%33'")(-#)%"0*JOT*3)"@*/$,0,"#-#)%"*-"&*T*3)"@*&)0('00)%"L*#%*7,*0,.,(#,&*
7>*#9,*0(),"#);(*(%33)##,,@*
**
OP@ZP*-3N*OO@PP*-3*R*4%I,,*X$,-C*
**
OO@PP*-3N*OO@ZP*-3R*Seminar+by+Dr.+Guillermo+Velasco+(Complutense+University,+Spain).+
“Pivotal+role+of+sphingolipids+on+the+stimulation+of+autophagy8mediated+cancer+cell+
death+by+cannabinoids”+
OO@ZP*-3N*OQ@PP*-3R*Seminar+by+Prof.+Toshiro+Okazaki+(Tottori+University,+Japan).+
“The*mechanism*to*overcome*the*chemo*resistance*of*leukemia*cells*through*
autophagic*cell*death”+
*
OQ@PP*-3N*O@PP*/3*:++Poster+Session+2+–+visit+of+stands+
**
O@PP*/3*NQ@ZP*/3*R*S'"(9*
**
Q@ZP*/3*_*b@ZP*/3*R*
Session+3+:+Cell+death+and+immune+responses**
49-)$/,$0%"0R*V$@*:$Y&Y$)(*H),'DNS-'(-#*J1-$)0E*:$-"(,LE*V$@*G)(%.-0*X)&c$,*J1-$)0E*:$-"(,L**
^*09%$#*%$-.*(%33'")(-#)%"0*JOT*3)"@*/$,0,"#-#)%"*-"&*T*3)"@*&)0('00)%"L*#%*7,*0,.,(#,&*
7>*#9,*0(),"#);(*(%33)##,,@*
**
b@ZP*/3*_*T@PP*/3R*4%I,,*7$,-C***
**
T@PP*/3N*T@bT*/3*R*Closing+lecture+by+Dr.+Pierre+Golstein+(Marseille8Luminy+
Immunology+center,+France).+«+Non8apoptotic+cell+death+in+a+model+organism+»*
**
T@bT*/3R*4%"(.'0)%"*_*d"&*%<*#9,*(%"2$,00@**
Cancer+cell+death+and+resistance*

Committees
Organiza'on*Commi?ee:5
]312-5H3:015Nh4:/5GLMNO6K5PK65bUed>5=1:)1:.(>5D3+0'(I55
]312-5=!/(33;5^(A+*(5GLMNO6K5PK65bUed>5=1:)1:.(>5D3+0'(I55
E3-5M+,!+)/(5@0*3/(:8@<+*/(5GLMNO6K5PK65bUed>5=1:)1:.(>5
D3+0'(I55
5
Z/,!5,!(5!()#5125
K3-5Nh<+.7(05_:/<(3,5GLMNO6K5PK65bUed>5=1:)1:.(>5D3+0'(I5
K3.5 K+3/(8@04i)(5 @)<1:;5 G]+:)5 N+<+7(35 P0/A(3./,;>5 =1:)1:.(5 LLL>5
D3+0'(I5
5
55
5
5
5
5
5
5*
Scien'fic*Commi?ee:5
E3-5J)/A/(35K/'!(+:5GLMNO6K5PK65QRR>5E/F10>5D3+0'(I555
E3-5]+,3/'&5^(4(9<3(5GLMNO6K5PK65bUQ\>56(00(.>5D3+0'(I5
E3-5D3h*h3/'56/(:`8^+:'+,5GLMNO6K5PK65dRQ>5]+3/.>5D3+0'(I5
E3-5O3/'5a!(A(,5GLMNO6K5bU\e>5H13*(+:`>5D3+0'(I55
E3-5M/'1)+.5H/*i3(5GLMNO6K5PK65bUbc>5]+3/.>5D3+0'(I55
E3-5S(+08O!3)+0*56/''/5GLMNO6K5bUR\>5M/'(>5D3+0'(I5
E3-5]!/)/##(5S:/05GLMNO6K5PK65QVT>5M+0,(.>5D3+0'(I55
E3-5 a+,!(3/0(5 ]())+,8E('(:0;0'&5GLMNO6K5PK65QVT>5
M+0,(.>5D3+0'(I5